ANI Pharmaceuticals
ANIP
ANIP
123 hedge funds and large institutions have $285M invested in ANI Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 41 increasing their positions, 36 reducing their positions, and 21 closing their positions.
Holders
123
Holders Change
+2
Holders Change %
+1.65%
% of All Funds
3.23%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
24
Increased
41
Reduced
36
Closed
21
Calls
$14.5M
Puts
$9.79M
Net Calls
+$4.75M
Net Calls Change
+$3.05M
Top Buyers
| 1 |
SAM
1
Senzar Asset Management
New York
|
$20.5M |
| 2 |
OAM
2
Oxford Asset Management
Oxford,
United Kingdom
|
$7.18M |
| 3 |
3
First Manhattan
New York
|
$6.96M |
| 4 |
4
Lazard Asset Management
New York
|
$2.77M |
| 5 |
5
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$9.89M |
